Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
1) To evaluate efficacy of treatment with BAY 85-3934 compared with darbepoetin alfa as measured by change from baseline to post-baseline time points in haemoglobin (Hb) levels. 2) To evaluate safety and tolerability of treatment with BAY 85-3934 compared with darbepoetin by events of special interest, adjudicated serious adverse events (SAEs), and SAEs.
Critère d'inclusion
- Anaemia of Chronic Kidney Disease